Status: current, Sufficiently defined by necessary conditions definition status. Date: 30-Apr 2022. Module: SNOMED CT core module
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
5036802013 | Product containing precisely cefalexin 250 milligram/1 each tablet for conventional release oral suspension (clinical drug) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
5036803015 | Cefalexin 250 mg tablet for oral suspension | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
5036804014 | Cephalexin 250 mg tablet for oral suspension | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Product containing precisely cefalexin 250 milligram/1 each tablet for conventional release oral suspension (clinical drug) | Is a | Product containing only cefalexin in oral dose form (medicinal product form) | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely cefalexin 250 milligram/1 each tablet for conventional release oral suspension (clinical drug) | Has manufactured dose form | Dispersible tablet | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely cefalexin 250 milligram/1 each tablet for conventional release oral suspension (clinical drug) | Has unit of presentation | Tablet | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely cefalexin 250 milligram/1 each tablet for conventional release oral suspension (clinical drug) | Plays role | Antibacterial therapeutic role | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely cefalexin 250 milligram/1 each tablet for conventional release oral suspension (clinical drug) | Has precise active ingredient | Cefalexin | true | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely cefalexin 250 milligram/1 each tablet for conventional release oral suspension (clinical drug) | Has basis of strength substance | Cefalexin | true | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely cefalexin 250 milligram/1 each tablet for conventional release oral suspension (clinical drug) | Has presentation strength numerator unit | milligram | true | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely cefalexin 250 milligram/1 each tablet for conventional release oral suspension (clinical drug) | Has presentation strength denominator unit | Tablet | true | Inferred relationship | Existential restriction modifier | 1 |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets